1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

European Journal of Immunology

Volumn 41, Issue 10, 2011, Pages 2937-2946

  Lee, Ji H ^a   Park, Sunyoung ^b   Cheon, Soyoung ^b   Lee, Joo H ^b   Kim, Sunghan ^c   Hur, Dae Y ^c   Kim, Tae S ^d   Yoon, Suk R ^e   Yang, Yoolhee ^f   Bang, Sa I ^f   Park, Hyunjeong ^g   Lee, Hoon T ^a,b   Cho, Daeho ^b  

^a Konkuk University   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^f Samsung Medical Center   (South Korea)

^g The Catholic University of Korea   (South Korea)

Author keywords

1 ,25(OH) 2D 3; Fas; HSP; Melanoma; NK cells

Indexed keywords

CALCITRIOL; FAS ANTIGEN; HEAT SHOCK PROTEIN 60;

APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CALCITRIOL; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CHAPERONIN 60; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MELANOMA; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 80053139927     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141597     Document Type: Article

References (55)

1. Deeb, K. K., Trump, D. L. and Johnson, C. S., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007. 7: 684-700.
2. Trump, D. L., Deeb, K. K. and Johnson, C. S., Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J. 2010. 16: 1-9.
3. Ravid, A., Rocker, D., Machlenkin, A., Rotem, C., Hochman, A., Kessler-Icekson, G., Liberman, U. A. and Koren, R., 1, 25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res. 1999. 59: 862-867.
4. Krishnan, A. V., Peehl, D. M. and Feldman, D., Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. J. Cell Biochem. 2003. 88: 363-371.
5. Osborne, J. E. and Hutchinson, P. E., Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br. J. Dermatol. 2002. 147: 197-213.
6. Garland, C. F. and Garland, F. C., Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 1980. 9: 227-231.
7. Blutt, S. E., McDonnell, T. J., Polek, T. C. and Weigel, N. L., Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 2000. 141: 10-17.
8. Park, W. H., Seol, J. G., Kim, E. S., Hyun, J. M., Jung, C. W., Lee, C. C., Binderup, L. et al., Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase. Br. J. Haematol. 2000. 109: 576-583.
9. Johnson, C. S., Hershberger, P. A. and Trump, D. L., Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev. 2002. 21: 147-158.
10. Danielsson, C., Fehsel, K., Polly, P. and Carlberg, C., Differential apoptotic response of human melanoma cells to 1 alpha, 25-dihydroxyvitamin D3 and its analogues. Cell Death Differ. 1998. 5: 946-952.
11. Evans, S. R., Houghton, A. M., Schumaker, L., Brenner, R. V., Buras, R. R., Davoodi, F., Nauta, R. J. and Shabahang, M., Vitamin D receptor and growth inhibition by 1, 25-dihydroxyvitamin D3 in human malignant melanoma cell lines. J. Surg. Res. 1996. 61: 127-133.
12. Essa, S., Denzer, N., Mahlknecht, U., Klein, R., Collnot, E. M., Tilgen, W. and Reichrath, J., VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells. J. Steroid Biochem. Mol. Biol. 2010. 121: 110-113.
13. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. and Moretta, A., Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol. Lett. 2005. 100: 7-13.
14. Trambas, C. M. and Griffiths, G. M., Delivering the kiss of death. Nat. Immunol. 2003. 4: 399-403.
15. Arase, H., Arase, N. and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 1995. 181: 1235-1238.
16. Lee, R. K., Spielman, J., Zhao, D. Y., Olsen, K. J. and Podack, E. R., Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 1996. 157: 1919-1925.
17. Okamoto, K., Kobayashi, T., Kobata, T., Hasunuma, T., Kato, T., Sumida, T. and Nishioka, K., Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes. Rheumatology (Oxford) 2000. 39: 471-480.
18. Carrington, P. E., Sandu, C., Wei, Y., Hill, J. M., Morisawa, G., Huang, T., Gavathiotis, E. et al., The structure of FADD and its mode of interaction with procaspase-8. Mol Cell 2006. 22: 599-610.
19. Scott, F. L., Stec, B., Pop, C., Dobaczewska, M. K., Lee, J. J., Monosov, E., Robinson, H. et al., The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature 2009. 457: 1019-1022.
20. Eberle, J., Fecker, L. F., Hossini, A. M., Wieder, T., Daniel, P. T., Orfanos, C. E. and Geilen, C. C., CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants. Oncogene 2003. 22: 9131-9141.
21. Kregel, K. C., Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J. Appl. Physiol. 2002. 92: 2177-2186.
22. Craig, E. A., Gambill, B. D. and Nelson, R. J., Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol. Rev. 1993. 57: 402-414.
23. Jolly, C. and Morimoto, R. I., Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 2000. 92: 1564-1572.
24. Ranford, J. C. and Henderson, B., Chaperonins in disease: mechanisms, models, and treatments. Mol. Pathol. 2002. 55: 209-213.
25. Chandra, D., Choy, G. and Tang, D. G., Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J. Biol. Chem. 2007. 282: 31289-31301.
26. Samali, A., Cai, J., Zhivotovsky, B., Jones, D. P. and Orrenius, S., Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 1999. 18: 2040-2048.
27. Harant, H., Spinner, D., Reddy, G. S. and Lindley, I. J., Natural metabolites of 1alpha, 25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. J. Cell Biochem. 2000. 78: 112-120.
28. Reichrath, J., Rech, M., Moeini, M., Meese, E., Tilgen, W. and Seifert, M., In vitro comparison of the vitamin D endocrine system in 1, 25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol. Ther. 2007. 6: 48-55.
29. Tam, Y. K., Maki, G., Miyagawa, B., Hennemann, B., Tonn, T. and Klingemann, H. G., Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 1999. 10: 1359-1373.
30. Bahram, S., Bresnahan, M., Geraghty, D. E. and Spies, T., A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 1994. 91: 6259-6263.
31. Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H. and Walczak, H., FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000. 12: 599-609.
32. Khazai, N., Judd, S. E. and Tangpricha, V., Calcium and vitamin D: skeletal and extraskeletal health. Curr. Rheumatol. Rep. 2008. 10: 110-117.
33. Mora, J. R., Iwata, M. and von Andrian, U. H., Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 2008. 8: 685-698.
34. Welsh, J., Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol. 1994. 72: 537-545.
35. Stewart, L. V. and Weigel, N. L., Vitamin D and prostate cancer. Exp. Biol. Med. (Maywood) 2004. 229: 277-284.
36. Han, J., Colditz, G. A. and Hunter, D. J., Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 2007. 28: 390-397.
37. Mocellin, S. and Nitti, D., Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 2008. 113: 2398-2407.
38. Norman, A. W., Mizwicki, M. T. and Norman, D. P., Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 2004. 3: 27-41.
39. Ma, Y., Yu, W. D., Kong, R. X., Trump, D. L. and Johnson, C. S., Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1, 25D3-mediated apoptosis in squamous cell carcinoma cells. Cancer Res. 2006. 66: 8131-8138.
40. Ivanov, V. N., Krasilnikov, M. and Ronai, Z., Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J. Biol. Chem. 2002. 277: 4932-4944.
41. Narvaez, C. J. and Welsh, J., Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J. Biol. Chem. 2001. 276: 9101-9107.
42. McGuire, T. F., Trump, D. L. and Johnson, C. S., Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J. Biol. Chem. 2001. 276: 26365-26373.
43. Danielsson, C., Torma, H., Vahlquist, A. and Carlberg, C., Positive and negative interaction of 1, 25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int. J. Cancer 1999. 81: 467-470.
44. Weitsman, G. E., Koren, R., Zuck, E., Rotem, C., Liberman, U. A. and Ravid, A., Vitamin D sensitizes breast cancer cells to the action of H2O2: mitochondria as a convergence point in the death pathway. Free Radic. Biol. Med. 2005. 39: 266-278.
45. Posner, G. H., Crawford, K. R., Peleg, S., Welsh, J. E., Romu, S., Gewirtz, D. A., Gupta, M. S. et al., A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin. Bioorg. Med. Chem. 2001. 9: 2365-2371.
46. Sundaram, S., Sea, A., Feldman, S., Strawbridge, R., Hoopes, P. J., Demidenko, E., Binderup, L. and Gewirtz, D. A., The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin. Cancer Res. 2003. 9: 2350-2356.
47. Cappello, F., Czarnecka, A. M., La Rocca, G., Di Stefano, A., Zummo, G. and Macario, A. J., Hsp60 and Hspl0 as antitumor molecular agents. Cancer Biol. Ther. 2007. 6: 487-489.
48. Cappello, F., Bellafiore, M., Palma, A., David, S., Marciano, V., Bartolotta, T., Sciume, C. et al., 60KDa chaperonin (HSP60) is over-expressed during colorectal carcinogenesis. Eur. J. Histochem. 2003. 47: 105-110.
49. Cappello, F., Rappa, F., David, S., Anzalone, R. and Zummo, G., Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res. 2003. 23: 1325-1331.
50. Cappello, F., Di Stefano, A., David, S., Rappa, F., Anzalone, R., La Rocca, G., D'Anna, S. E. et al., Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer 2006. 107: 2417-2424.
51. Hansen, J. J., Bross, P., Westergaard, M., Nielsen, M. N., Eiberg, H., Borglum, A. D., Mogensen, J. et al., Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum. Genet. 2003. 112: 71-77.
52. Lu, J., Park, J. H., Liu, A. Y. and Chen, K. Y., Activation of heat shock factor 1 by hyperosmotic or hypo-osmotic stress is drastically attenuated in normal human fibroblasts during senescence. J. Cell Physiol. 2000. 184: 183-190.
53. Chun, J. N., Choi, B., Lee, K. W., Lee, D. J., Kang, D. H., Lee, J. Y., Song, I. S. et al., Cytosolic Hsp60 is involved in the NF-kappaB-dependent survival of cancer cells via IKK regulation. PLoS One 2010. 5: e9422.
54. Karin, M. and Ben-Neriah, Y., Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000. 18: 621-663.
55. Kimura, M., Haisa, M., Uetsuka, H., Takaoka, M., Ohkawa, T., Kawashima, R., Yamatsuji, T. et al., TNF combined with IFN-alpha accelerates NF-kappaB-mediated apoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ. 2003. 10: 718-728.